PhaseRx Secures $5,200,053 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=982945a4-0d48-4937-a044-3891ebe565fe&Preview=1 -
Date
7/9/2012 -
Company Name
PhaseRx -
Mailing Address
410 West Harrison Street Seattle, WA 98119 -
Company Description
The company is developing therapies via sIRNA technologies. -
Website
http://www.phaserx.com -
Transaction Type
Debt -
Transaction Amount
$5,200,053 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filings – amended. -
M&A Terms
-
Venture Investor
Undisclosed
